Menu
Medical Condition
Ophthalmology / Eye Care
Ophthalmology / Eye Care ICD-10: B87.2

Ocular Myiasis

Infestation of ocular tissues by larvae of Diptera flies.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

Patient reports severe itching and foreign body sensation after travel to tropical areas.

General Examination

Unremarkable or not routinely indicated.

Treatment Protocol

Mechanical removal of larvae and topical antibiotics.

Patient Education

Hygiene education and protection against insects.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: Abdomen soft, non-tender. AR: البطن لين ولا يوجد ألم.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.

Dermatological

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Psychiatric

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

OB/GYN

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Ophthalmic

EN: Slit-lamp reveals motile larvae on the conjunctiva. AR: المصباح الشقي يكشف عن يرقات متحركة على الملتحمة.

Dental

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Clinical Compendium: Ocular Myiasis

1. Comprehensive Introduction & Overview

Ocular myiasis is a rare, parasitic infestation of the ocular tissues—including the conjunctiva, eyelids, or orbit—by the larvae (maggots) of various dipterous fly species. While more common in tropical and subtropical regions, globalization and increased international travel have made this a relevant differential diagnosis for ophthalmologists globally.

The term "myiasis" is derived from the Greek myia (fly). When these larvae invade the human eye, they cause significant inflammation, irritation, and, in severe cases, permanent ocular damage. Clinical presentation can range from benign, self-limiting external infestation to sight-threatening intraocular penetration.

Epidemiological Context

The incidence of ocular myiasis is highest in rural populations, particularly those living in close proximity to livestock or in areas with poor sanitation. However, it is an opportunistic condition that does not discriminate based on socioeconomic status, provided the vector is present.


2. Etiology and Pathophysiology

The Primary Vectors

The causative agents are primarily members of the order Diptera. The flies do not typically require a wound to deposit eggs; they are often attracted to ocular secretions (tears, pus, or blood).

Family Common Species Characteristics
Oestridae Oestrus ovis The sheep botfly; most common cause of external ocular myiasis.
Calliphoridae Cochliomyia hominivorax New World screwworm; highly aggressive, tissue-destructive.
Sarcophagidae Wohlfahrtia magnifica Flesh flies; known for deep tissue invasion.

Pathophysiological Mechanism

  1. Oviposition: The adult female fly deposits eggs or first-instar larvae directly into the eye or near the eyelid.
  2. Larval Migration: The larvae utilize oral hooks and body spines to anchor themselves to the conjunctiva or penetrate deeper tissues.
  3. Host Response: The presence of the larvae triggers a potent immune response. Proteolytic enzymes secreted by the larvae to digest host tissue cause necrosis, edema, and intense neutrophilic infiltration.
  4. Complications: If the larvae breach the globe, they can cause endophthalmitis, retinal detachment, or even intracranial extension.

3. Clinical Staging and Presentation

Ocular myiasis is categorized based on the anatomical site of infestation.

External Ophthalmomyiasis

This is the most common form, involving the conjunctival sac.
* Symptoms: Intense foreign body sensation, lacrimation, photophobia, and blurred vision.
* Clinical Findings: "Crawling" sensation, conjunctival hyperemia, chemosis, and the presence of motile, translucent larvae within the fornices.

Internal Ophthalmomyiasis

A rare, severe manifestation where larvae penetrate the sclera into the vitreous or subretinal space.
* Anterior Segment: Larvae may be visible in the anterior chamber.
* Posterior Segment: Larvae may be seen moving beneath the retina or within the vitreous cavity, often leading to inflammatory vitreous bands and potential retinal detachment.

Orbital Myiasis

This involves the destruction of orbital tissues. It is most common in debilitated patients or those with large, necrotic wounds. It can result in complete ophthalmoplegia and loss of the globe.


4. Diagnostic Protocols and Differential Diagnosis

Key Diagnostic Tests

  1. Slit-Lamp Biomicroscopy: The gold standard for identifying larvae in the conjunctival sac.
  2. Indirect Ophthalmoscopy: Essential for identifying larvae in the posterior segment.
  3. B-Scan Ultrasonography: Used when media opacities (cataract, vitreous hemorrhage) prevent direct visualization.
  4. Imaging (CT/MRI): Indicated for orbital myiasis to assess the extent of tissue destruction and rule out intracranial involvement.

Differential Diagnosis Table

Diagnosis Distinguishing Feature
Conjunctivitis Bacterial/viral usually lacks visible macro-parasites.
Foreign Body Inert objects do not move; larvae exhibit active, undulating motion.
Allergic Conjunctivitis Lacks the specific localized burrowing tracks of larvae.
Orbital Cellulitis Usually associated with systemic fever and sinus disease.

5. Clinical Management and Treatment

Mechanical Removal

The cornerstone of treatment for external ophthalmomyiasis is the physical removal of the larvae using fine forceps under topical anesthesia.
* Technique: Apply a drop of viscous lidocaine or cocaine to immobilize the larvae, followed by careful extraction.
* Follow-up: Thorough irrigation of the conjunctival sac with saline to ensure no eggs remain.

Pharmacological Intervention

  • Topical Antibiotics: To prevent secondary bacterial infection of the damaged conjunctival epithelium.
  • Systemic Antiparasitics: In cases of deep tissue invasion, oral Ivermectin has been used with success to paralyze larvae, though it is not a first-line treatment for simple conjunctival cases.

6. Risks, Side Effects, and Contraindications

Potential Risks

  • Globe Perforation: Aggressive larval burrowing can lead to scleral rupture.
  • Secondary Infection: The introduction of bacteria via larval movement can lead to orbital cellulitis or necrotizing fasciitis.
  • Permanent Vision Loss: Resulting from retinal scarring, toxic retinopathy, or phthisis bulbi.

Contraindications

  • Do not use strong chemical agents: Attempting to kill larvae with concentrated alcohol or harsh antiseptics can cause severe chemical burns to the cornea.
  • Avoid delayed surgical exploration: If internal myiasis is suspected, do not wait for "natural resolution." Surgical intervention (vitrectomy) is required to prevent irreversible retinal damage.

7. Prognosis

  • External Myiasis: Generally excellent. Full recovery is typical once the larvae are removed.
  • Internal Myiasis: Guarded. Even with successful removal of the larvae, the mechanical and toxic damage to the retina often leaves the patient with permanent visual field deficits or central vision loss.

8. Frequently Asked Questions (FAQ)

1. How do flies manage to infest the human eye?

Flies are attracted to odors. Tears, eye discharge, or blood from a minor injury act as a beacon. The fly deposits eggs or live larvae (depending on the species) while the host is sleeping or outdoors.

2. Is ocular myiasis painful?

Yes. Patients typically describe a "crawling" sensation, extreme irritation, and a feeling that something is moving inside their eye, which is often accompanied by significant pain.

3. Can I remove the larvae at home?

No. Attempting to remove larvae at home can lead to the larvae burrowing deeper or causing mechanical damage to the cornea. Professional ophthalmological tools are required.

4. Is the condition contagious?

No, ocular myiasis is not transmitted from person to person. It is an infestation caused by environmental vectors.

5. What is the difference between external and internal myiasis?

External myiasis stays on the surface (conjunctiva/eyelid). Internal myiasis involves the larva penetrating the sclera, which can lead to blindness.

6. Do all maggots look the same in the eye?

No. Different species have different sizes, colors, and hook structures. A specialist will identify the species to determine the potential risk of systemic or orbital invasion.

7. How long can a larva live in the eye?

If left untreated, larvae can survive until they complete their developmental stage, which can take several days to weeks, during which time they cause progressive tissue destruction.

8. Will I need surgery?

For external cases, a simple bedside extraction is usually sufficient. For internal cases, a pars plana vitrectomy is often required to remove the larva and clear the vitreous of inflammatory debris.

9. How can I prevent ocular myiasis?

Use insect repellents, wear protective eyewear when working in rural or livestock-heavy areas, and ensure good ocular hygiene. Promptly treat any eye injuries.

10. Does this only happen to people with poor hygiene?

While poor sanitation is a risk factor, anyone can be affected. It is an opportunistic event, and even healthy individuals in endemic regions are susceptible.


9. Conclusion

Ocular myiasis represents a unique intersection between parasitology and ophthalmology. While the external form is often a straightforward clinical encounter, the potential for internal, vision-threatening progression necessitates a high index of suspicion. Prompt identification, meticulous mechanical extraction, and diligent follow-up are the standards of care that define the clinical management of this condition. Clinicians must remain vigilant, particularly when presented with patients complaining of persistent "crawling" sensations or unexplained acute conjunctivitis in endemic regions.

Treatment & Management Options

Recommended Medications

Share this guide: